Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Jul-Aug;96(6):371-5.
doi: 10.1016/s0001-7310(05)73093-3.

[Comparative study of the treatment of psoriasis plaques with PUVA baths and narrow-band UVA (311 nm)]

[Article in Spanish]
Affiliations
Free article
Clinical Trial

[Comparative study of the treatment of psoriasis plaques with PUVA baths and narrow-band UVA (311 nm)]

[Article in Spanish]
Elena Rosón et al. Actas Dermosifiliogr. 2005 Jul-Aug.
Free article

Abstract

Introduction: Studies carried out to date comparing treatment with PUVA baths and narrow-band UVB (NBUVB) in psoriasis show that better results are obtained with NBUVB. Certain features of the protocols may interfere with the results.

Material and methods: Prospective study in a psoriasis unit, with treatment assigned according to availability. Of 167 patients with psoriasis plaques, 32 received PUVA baths (photosensitizer 8-methoxypsoralen at a concentration of 2.6 mg/l) and 135 received NBUVB radiation. A clearing rate of over 70 % was considered a good response. The data were described and compared between the two groups, including multivariate analysis techniques, in order to statistically control the effects of gender, number of sessions necessary for success, minimum phototoxic dose and minimum erythema dose.

Results: A good response was obtained in 87.5 % of the cases with PUVA baths (95 % CI: 71.0-96.5) and in 87.4 % of the cases with NBUVB (95 % CI: 80.6-92.5). No significant differences were found in the success and abandonment percentages. Among the patients who responded to the treatment, no differences were found in the number of sessions or in the cumulative dose. Gender, cumulative dose or minimum phototoxic dose and minimum erythema dose values were not associated with the response to the treatments either.

Conclusions: With psoriasis plaques, similar response percentages can be expected with both treatments, using the proposed protocols. The response is regardless of gender, cumulative dose and minimum phototoxic dose and minimum erythema dose values.

PubMed Disclaimer

LinkOut - more resources